290 related articles for article (PubMed ID: 27891768)
1. Hyperuricaemia and risk of nonalcoholic fatty liver disease: A meta-analysis.
Wijarnpreecha K; Panjawatanan P; Lekuthai N; Thongprayoon C; Cheungpasitporn W; Ungprasert P
Liver Int; 2017 Jun; 37(6):906-918. PubMed ID: 27891768
[TBL] [Abstract][Full Text] [Related]
2. Hyperuricemia is associated with nonalcoholic fatty liver disease activity score in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Jaruvongvanich V; Ahuja W; Wirunsawanya K; Wijarnpreecha K; Ungprasert P
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1031-1035. PubMed ID: 28639970
[TBL] [Abstract][Full Text] [Related]
3. Hyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Jaruvongvanich V; Ahuja W; Wijarnpreecha K; Ungprasert P
Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):694-697. PubMed ID: 28252464
[TBL] [Abstract][Full Text] [Related]
4. Association between gastroesophageal reflux disease and nonalcoholic fatty liver disease: A meta-analysis.
Wijarnpreecha K; Panjawatanan P; Thongprayoon C; Jaruvongvanich V; Ungprasert P
Saudi J Gastroenterol; 2017; 23(6):311-317. PubMed ID: 29205182
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic Fatty Liver Disease and Urolithiasis. A Systematic Review and Meta-Analysis.
Wijarnpreecha K; Lou S; Panjawatanan P; Sanguankeo A; Pungpapong S; Lukens FJ; Ungprasert P
J Gastrointestin Liver Dis; 2018 Dec; 27(4):427-432. PubMed ID: 30574625
[TBL] [Abstract][Full Text] [Related]
6. The association between non-alcoholic fatty liver disease and atrial fibrillation: A meta-analysis.
Wijarnpreecha K; Boonpheng B; Thongprayoon C; Jaruvongvanich V; Ungprasert P
Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):525-532. PubMed ID: 28866089
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease and albuminuria: a systematic review and meta-analysis.
Wijarnpreecha K; Thongprayoon C; Boonpheng B; Panjawatanan P; Sharma K; Ungprasert P; Pungpapong S; Cheungpasitporn W
Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):986-994. PubMed ID: 29787418
[TBL] [Abstract][Full Text] [Related]
8. Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis.
Wijarnpreecha K; Panjawatanan P; Thongprayoon C; Jaruvongvanich V; Ungprasert P
Saudi J Gastroenterol; 2018; 24(1):12-17. PubMed ID: 29451179
[TBL] [Abstract][Full Text] [Related]
9. High serum uric acid and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis.
Zhou Y; Wei F; Fan Y
Clin Biochem; 2016 May; 49(7-8):636-42. PubMed ID: 26738417
[TBL] [Abstract][Full Text] [Related]
10. Association between diastolic cardiac dysfunction and nonalcoholic fatty liver disease: A systematic review and meta-analysis.
Wijarnpreecha K; Lou S; Panjawatanan P; Cheungpasitporn W; Pungpapong S; Lukens FJ; Ungprasert P
Dig Liver Dis; 2018 Nov; 50(11):1166-1175. PubMed ID: 30292566
[TBL] [Abstract][Full Text] [Related]
11. Hyperuricemia and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Gong S; Song J; Wang L; Zhang S; Wang Y
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):132-8. PubMed ID: 26545082
[TBL] [Abstract][Full Text] [Related]
12. Higher Serum Uric Acid Level Predicts Non-alcoholic Fatty Liver Disease: A 4-Year Prospective Cohort Study.
Wei F; Li J; Chen C; Zhang K; Cao L; Wang X; Ma J; Feng S; Li WD
Front Endocrinol (Lausanne); 2020; 11():179. PubMed ID: 32328031
[No Abstract] [Full Text] [Related]
13. Association between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis.
Darmawan G; Hamijoyo L; Hasan I
Acta Med Indones; 2017 Apr; 49(2):136-147. PubMed ID: 28790228
[TBL] [Abstract][Full Text] [Related]
14. Short sleep duration and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis.
Wijarnpreecha K; Thongprayoon C; Panjawatanan P; Ungprasert P
J Gastroenterol Hepatol; 2016 Nov; 31(11):1802-1807. PubMed ID: 27029776
[TBL] [Abstract][Full Text] [Related]
15. Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk?
Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP
Curr Vasc Pharmacol; 2011 Nov; 9(6):698-705. PubMed ID: 21388346
[TBL] [Abstract][Full Text] [Related]
16. Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females.
Wang L; Guo J; Lu J
Oncotarget; 2016 Jun; 7(24):35632-35642. PubMed ID: 27248665
[TBL] [Abstract][Full Text] [Related]
17. Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Wijarnpreecha K; Lou S; Watthanasuntorn K; Kroner PT; Cheungpasitporn W; Lukens FJ; Pungpapong S; Keaveny AP; Ungprasert P
Eur J Gastroenterol Hepatol; 2020 May; 32(5):601-608. PubMed ID: 31567712
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of nonalcoholic fatty liver disease and relationship with serum uric acid level in Uyghur population.
Cai W; Song JM; Zhang B; Sun YP; Yao H; Zhang YX
ScientificWorldJournal; 2014; 2014():393628. PubMed ID: 24516367
[TBL] [Abstract][Full Text] [Related]
19. Gender effect of hyperuricemia on the development of nonalcoholic fatty liver disease (NAFLD): A clinical analysis and mechanistic study.
Xu K; Zhao X; Fu X; Xu K; Li Z; Miao L; Li Y; Cai Z; Qiao L; Bao J
Biomed Pharmacother; 2019 Sep; 117():109158. PubMed ID: 31252266
[TBL] [Abstract][Full Text] [Related]
20. Effects of inflammatory bowel disease treatment on the risk of nonalcoholic fatty liver disease: a meta-analysis.
Lapumnuaypol K; Kanjanahattakij N; Pisarcik D; Thongprayoon C; Wijarnpreecha K; Cheungpasitporn W
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):854-860. PubMed ID: 29697458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
